SweetValueLab
Write for us

HCA Healthcare, Inc. — Wall Street Analyst Estimates & Price Targets

HCA
NYSEHealthcareMedical - Care FacilitiesCIK 0000860730hcahealthcare.comAbout HCA
Last close · Oct 16, 2026458.84−9.66 (−2.06%)
Market cap$99.3B

11 firms' latest targets, last 90 days: median $476.00 ($369.00–$579.00), 4% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$400$500$600NovJan 2026MarMayJulSep2025-10-17 · Mizuho Securities: $4752025-10-27 · Truist: $4952025-10-27 · Stephens: $5002025-10-27 · RBC Capital: $4822025-10-27 · Barclays: $4942025-10-27 · UBS: $5252025-10-27 · Morgan Stanley: $4252025-10-27 · Goldman Sachs: $5202025-10-27 · Raymond James: $5252025-10-27 · Oppenheimer: $5002025-10-27 · Mizuho Securities: $5052025-10-27 · Bernstein: $4172025-12-18 · Mizuho Securities: $5202026-01-06 · Bernstein: $5032026-01-07 · Wells Fargo: $4522026-01-22 · KeyBanc: $5002026-01-28 · RBC Capital: $5552026-01-28 · KeyBanc: $5032026-01-28 · UBS: $5982026-01-28 · Oppenheimer: $5402026-01-28 · UBS: $5882026-01-28 · KeyBanc: $5502026-01-28 · Barclays: $5512026-01-30 · Wells Fargo: $4812026-02-02 · Mizuho Securities: $5402026-02-09 · Bernstein: $5412026-02-23 · UBS: $6352026-04-24 · Jefferies: $5252026-04-27 · Stephens: $5302026-04-27 · Truist: $5352026-04-27 · Oppenheimer: $5202026-04-27 · RBC Capital: $5342026-04-27 · Wells Fargo: $4362026-04-27 · KeyBanc: $5102026-04-27 · Barclays: $4962026-06-04 · Truist: $4132026-06-04 · Bernstein: $4132026-07-07 · Raymond James: $5282026-07-07 · Cantor Fitzgerald: $5252026-07-08 · Barclays: $4272026-07-13 · Wells Fargo: $4282026-07-14 · Jefferies: $4502026-07-15 · RBC Capital: $4352026-07-16 · Barclays: $4022026-07-20 · Wells Fargo: $3692026-07-27 · UBS: $5792026-07-27 · Deutsche Bank: $4762026-07-27 · Morgan Stanley: $3802026-07-27 · Oppenheimer: $4852026-07-27 · Baird: $3932026-07-27 · Barclays: $3872026-07-27 · KeyBanc: $4352026-07-28 · Goldman Sachs: $4852026-09-22 · BMO Capital: $4952026-10-07 · RBC Capital: $496
$400$500$600NovFebMayAug

Each firm's latest target

last 90 days · 11 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-07RBC Capital$496.00$435.00▲ 14%+13%+8%
2026-09-22BMO Capital$495.00——+13%+8%
2026-07-28Goldman Sachs$485.00$520.00▼ 7%+24%+6%
2026-07-27UBS$579.00$635.00▼ 9%+48%+26%
2026-07-27Deutsche Bank$476.00——+23%+4%
2026-07-27Morgan Stanley$380.00$425.00▼ 11%-2%-17%
2026-07-27Oppenheimer$485.00$520.00▼ 7%+25%+6%
2026-07-27Baird$393.00——+3%-14%
2026-07-27Barclays$387.00$402.00▼ 4%+1%-16%
2026-07-27KeyBanc$435.00$510.00▼ 15%+14%-5%
2026-07-20Wells Fargo$369.00$428.00▼ 14%-1%-20%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2023reported$65.0B+8%$18.97-1%est. $64.2B+1%est. $18.2015
2024reported$70.6B+9%$22.00+16%est. $70.6B+0%est. $21.9415
2025reported$75.6B+7%$28.33+29%est. $75.7B+0%est. $27.6816
2026$78.5B+4%$29.50+7%$77.9B–$79.1B$29.14–$30.0819
2027$81.5B+4%$32.11+9%$80.1B–$82.8B$30.22–$34.0619
2028$85.3B+5%$35.33+10%$82.4B–$87.6B$32.85–$38.4017
2029$91.0B+7%$39.24+11%$89.2B–$92.4B$38.20–$40.0313
2030$96.3B+6%$44.81+14%$94.3B–$97.8B$43.63–$45.708
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.